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The activation of Wnt/b-catenin signalling has an impor-
tant function in gastrointestinal tumorigenesis. It has been
suggested that the promotion of Wnt/b-catenin activity
beyond the threshold is important for carcinogenesis. We
herein investigated the role of macrophages in the promo-
tion of Wnt/b-catenin activity in gastric tumorigenesis. We
found b-catenin nuclear accumulation in macrophage-
inﬁltrated dysplastic mucosa of the K19-Wnt1 mouse
stomach. Moreover, macrophage depletion in Apc
D716
mice resulted in the suppression of intestinal tumorigen-
esis. These results suggested the role of macrophages in the
activation of Wnt/b-catenin signalling, which thus leads to
tumour development. Importantly, the conditioned med-
ium of activated macrophages promoted Wnt/b-catenin
signalling in gastric cancer cells, which was suppressed
by the inhibition of tumour necrosis factor (TNF)-a.
Furthermore, treatment with TNF-a induced glycogen
synthase kinase 3b (GSK3b) phosphorylation, which re-
sulted in the stabilization of b-catenin. We also found that
Helicobacter infection in the K19-Wnt1 mouse stomach
caused mucosal macrophage inﬁltration and nuclear
b-catenin accumulation. These results suggest that macro-
phage-derived TNF-a promotes Wnt/b-catenin signalling
through inhibition of GSK3b, which may contribute to
tumour development in the gastric mucosa.
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Introduction
The canonical Wnt signalling pathway (Wnt/b-catenin path-
way) operates by stabilizing b-catenin (Taketo, 2006). The
phosphorylation of b-catenin by glycogen synthase kinase 3b
(GSK3b) results in degradation through the ubiquitin path-
way. The binding of Wnt ligands to a Frizzled receptor leads
to inhibition of the b-catenin degradation complex consisting
of APC, AXIN and GSK3b thereby allowing the nuclear
translocation of stabilized b-catenin followed by transcrip-
tional activation of the Wnt target genes. Wnt/b-catenin
signalling has an important function in the maintenance of
intestinal stem cells and progenitor cells (Korinek et al, 1998;
van de Wetering et al, 2002), and its activation causes
gastrointestinal tumour development (Oshima et al, 1995,
2006; Fodde et al, 2001).
The activation level of Wnt/b-catenin signalling has been
reported to be a determining factor for the multiplicity of
intestinal polyposis in several types of Apc gene mutant mice
(Gaspar and Fodde, 2004; Li et al, 2005). Moreover, nuclear b-
catenin accumulation is predominantly observed in the inva-
sion front of colon cancer in comparison to the non-invasive
tumour area (Brabletz et al, 1998). Furthermore, sensitivity of
embryonic stem (ES) cells for differentiation is inhibited by
increase of Wnt/b-catenin signalling activity (Kielman et al,
2002). These results, taken together, suggest that the promo-
tion of the Wnt/b-catenin activity beyond the threshold level
is required for tumorigenesis, invasion and the maintenance
of cell stemness.
On the other hand, it has been established that inﬂamma-
tion has an important function in cancer development
(Coussens and Werb, 2002). The activation of tumour necro-
sis factor (TNF)-a or NF-kB pathway is required for the
development of hepatocellular carcinoma (Pikarsky et al,
2004) and intestinal tumours (Greten et al, 2004;
Popivanova et al, 2008) through the induction of growth
factors and suppression of apoptosis. Although several sig-
nalling pathways have been reported for the promotion of
Wnt/b-catenin activity (Fodde and Brabletz, 2007), it has not
been elucidated yet whether the inﬂammatory response con-
tributes to the promotion of Wnt/b-catenin signalling during
tumorigenesis.
Gastric cancer is the second most common cancer in the
world and it is closely associated with Helicobacter
pylori infection, which leads to chronic inﬂammation
(Correa, 2003). Moreover, the activation of the Wnt/b-catenin
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1671signalling is found in about 30% of gastric cancer (Clements
et al, 2002), suggesting that Wnt activation is one of the
major causes for gastric cancer development. We recently
showed that cooperation of Wnt signalling and prostaglandin
E2 (PGE2) pathway causes gastric cancer development in a
transgenic mouse model (Oshima et al, 2006). Because
the activation of PGE2 signalling induces inﬁltration and
activation of macrophages in the gastric mucosa (Oshima
et al, 2004, 2005), these results collectively suggest that
activated macrophages promote the Wnt/b-catenin signalling
activity, which thus contributes to gastric cancer.
We herein show that TNF-a derived from activated
macrophages promotes the Wnt/b-catenin activity in gastric
cancer cells through the suppression of GSK3b. Moreover,
Helicobacter infection in the Wnt1 transgenic mice resulted in
macrophage inﬁltration and the activation of Wnt/b-catenin
signalling in the gastric mucosa, which thus led to
gastric tumorigenesis. These results suggest that activated
macrophages in inﬂammatory microenvironment have an
important function in gastric tumorigenesis through the
promotion of the Wnt/b-catenin activity.
Results
Macrophage inﬁltration and b-catenin nuclear
accumulation in gastric dysplasia of K19-Wnt1
transgenic mice
K19-Wnt1 transgenic mice expressing Wnt1 in the gastric
epithelial cells develop sporadic dysplastic lesions in the
glandular stomach (Oshima et al, 2006). In these dysplastic
lesions, inﬂammatory cells inﬁltrated the submucosa,
whereas cell inﬁltration was rarely detected in the adjacent
normal mucosa (Figure 1A). By immunostaining, we found
macrophage inﬁltration in the dysplastic mucosa, whereas
tissue macrophages were only sparsely scattered in the
normal mucosa (Figure 1B and H). We also found strong
nuclear staining of b-catenin in the epithelial cells of the
dysplastic mucosa (Figure 1C). Notably, b-catenin-accumu-
lated epithelial cells were physically associated with stromal
macrophages in the dysplastic lesions (Figure 1E). In con-
trast, mild b-catenin accumulation was found only in the cell
proliferation zone of the normal mucosa (Figure 1I). We
conﬁrmed the increase in the b-catenin-positive index in
the dysplastic lesion to be associated with the increased
number of inﬁltrated macrophages (Figure 1F). Moreover,
the number of Ki-67-positive proliferating cells increased in
the dysplastic mucosa when compared with that in the
adjacent normal region (Figure 1D and J). The mean Ki-67
labelling indices in the dysplastic lesions and normal mucosa
were 43 and 15%, respectively (P¼0.007). We also con-
ﬁrmed by BrdU incorporation analysis that cell proliferation
was increased in dysplastic lesions (Figure 1G). On the basis
of these results, we hypothesized that macrophage inﬁltration
by inﬂammatory responses causes promotion of Wnt/
b-catenin signalling activity in gastric epithelial cells, which
probably leads to dysplastic changes in the gastric mucosa.
Requirement of macrophages for intestinal tumour
development in Apc
D716 mice
To examine whether inﬁltrated macrophages are required for
tumorigenesis, we performed crossing experiments using
op/op mice, in which the number of macrophages
signiﬁcantly decreased in the majority of tissues because of
Csf1 mutation (Cecchini et al, 1994). We ﬁrst examined
whether op/op mutation suppressed macrophage inﬁltration
in the inﬂamed stomach using K19-C2mE mice, which
develop gastritis with heavy macrophage accumulation
(Oshima et al, 2004). However, mucosal macrophages were
still found in the stomach of the K19-C2mE op/op compound
mice (Supplementary Figure 1). We therefore crossed op/op
mice with Apc
D716 mice, a model for intestinal polyposis
caused by Wnt activation (Oshima et al, 1995). Apc
D716
mice develop numerous polyps in entire intestinal tract
(Figure 2A), and macrophages were inﬁltrated in the polyp
stroma (Figure 2B). Interestingly, Apc
D716 op/op compound
mice showed dramatic suppression of intestinal polyposis
(Figure 2C and E), and macrophages were not found in the
polyp tissues (Figure 2D). Moreover, the number of polyps
41mm signiﬁcantly decreased in Apc
D716 op/op compound
mice by 80% compared with Apc
D716 mice. Although it
remains to be elucidated as to whether the loss of
the CSF-1 function affects tumorigenesis, these results
suggest that macrophages were required for the growth of
Wnt/b-catenin-activated tumour cells. Consistently, the BrdU
labelling index also decreased in Apc
D716 op/op mouse
tumours (Figure 2F).
Fluctuation of Wnt/b-catenin signalling activity
in gastric cancer cells
We next examined the regulation of the Wnt/b-catenin sig-
nalling activity by in vitro experiments using human gastric
cancer cells, AGS and Kato-III. AGS cells harbour a hetero-
zygous mutation in the b-catenin gene (CTNNB1) at codon 34
(Caca et al, 1999; Supplementary Figure 2), whereas CTNNB1
is ampliﬁed in Kato-III cells (Suriano et al, 2005). Consistent
with the previous results (Nojima et al, 2007), both cell lines
showed an elevated b-catenin/TCF transcriptional activity as
detected by a TOPFLASH assay (Supplementary Figure 3). By
immunocytochemistry, the cytoplasmic and nuclear accumu-
lation of b-catenin was found in both AGS and Kato-III cells
(Figure 3A, left). We also found the nuclear localization of
active form of b-catenin, unphosphorylated on Ser37 and
Thr41 (van Noort et al, 2002; Figure 3A, right), thus indicat-
ing the activation of Wnt/b-catenin signalling. However,
several cells showed a weak b-catenin staining intensity
(Figure 3A, arrowheads), suggesting that the level of
Wnt/b-catenin signalling activity varies in populations.
To examine the Wnt/b-catenin activity in the live cells, we
transfected a TOPEGFP vector that expressed a green ﬂuor-
escent protein (GFP) in response to b-catenin/TCF transcrip-
tional activity (Figure 3B), and established AGS–GFP and
Kato-III–GFP cell lines. We conﬁrmed that GFP expression
was induced in b-catenin accumulated cells after the transient
transfection of mutant CTNNB1 (S33A) expression vector
(Figure 3C). Importantly, we directly found by time-lapse
video analysis that the Wnt/b-catenin activity was not con-
stant but ﬂuctuated in individual AGS–GFP cells
(Supplementary Video 1).
To conﬁrm the ﬂuctuation of Wnt/b-catenin activity, we
isolated by cell sorting the high-GFP (top 5%) and low-GFP
(bottom 5%) populations corresponding to high and low
Wnt/b-catenin signalling activity, respectively, from AGS–
GFP and Kato-III–GFP cells (Figure 3D, left). Immediately
after isolation, both populations showed distinct GFP
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intensities of the isolated populations returned to a similar
distribution to the unsorted cells after culturing for 5 days
(Figure 3D, right). These results conﬁrmed that the activation
level of Wnt/b-catenin signalling ﬂuctuates in each cell.
We next examined the level of Wnt/b-catenin activity in
cell cycle-synchronized Kato-III–GFP cells. However, the ratio
of a high-GFP population did not change during cell cycling,
thus indicating Wnt/b-catenin ﬂuctuation to be independent
of the cell cycle status (Supplementary Figure 4).
Promotion of Wnt/b-catenin activity in gastric cancer
cells by activated macrophages and TNF-a
We next examined whether the activity of Wnt/b-catenin
signalling is promoted by activated macrophages using the
GFP reporter-transfected cells. We prepared a conditioned
medium of macrophage cell line, RAW264, activated with
lipopolysaccharide (LPS) for 24h; (hereafter, CM-LPS (þ)).
A conditioned medium from unstimulated RAW264 cells was
used as the control (CM-LPS ( )). When AGS–GFP and Kato-
III–GFP cells were stimulated with CM-LPS (þ), the high-
GFP population (corresponding to top 2% in the untreated
control cells) signiﬁcantly increased in a CM concentration-
dependent manner (Figure 4A and B, left and top, red area).
In contrast, stimulation of the cells with CM-LPS ( ) or LPS
alone did not affect the Wnt/b-catenin activity in either cell
line (Figure 4A and B, middle and bottom). These results
indicate that the soluble factor(s) derived from activated
macrophages promote the Wnt/b-catenin activity in gastric
cancer cells.
TNF-a is a key mediator for inﬂammation and is produced
by activated macrophages. Notably, treatment of the cells
with a neutralizing antibody against TNF-a signiﬁcantly
suppressed the effect by CM-LPS (þ) to enhance the
Wnt/b-catenin activity in both cell lines (Figure 4C).
Furthermore, direct treatment with TNF-a increased the
level of Wnt/b-catenin activity (Figure 4D). We detected the
expression of both TNF R1 and TNF R2 on AGS and Kato-III
cells as well as in the primary cultured gastric epithelial cells
(Supplementary Figure 5A and C and data not shown).
Importantly, the blockade of either receptor by neutralizing
antibody signiﬁcantly suppressed the TNF-a-induced Wnt/
b-catenin activation (Supplementary Figure 5B). These
results suggest that TNF-a signalling through both TNF R1
and TNF R2 is thus involved in the promotion of the Wnt/
b-catenin activity. By immunohistochemistry, we found most
TNF-a-expressing cells in gastric tumours to be macrophages,
whereas CD11c-positive dendritic cells were rarely detected
(Supplementary Figure 6A). Importantly, treatment of
the K19-Wnt1 mice with anti-TNF-a-neutralizing antibody
resulted in a decrease of the b-catenin immunostaining
intensity in the dysplastic lesions (Supplementary Figure 6B).
Figure 1 Macrophage accumulation and nuclear localization of b-catenin in dysplastic lesion of the K19-Wnt1 mouse stomach.
(A) Representative histology of a dysplastic lesion in the K19-Wnt1 glandular stomach (H&E staining). The arrowheads indicate the dysplastic
mucosal area. The arrows indicate submucosal inﬂammatory inﬁltration. High-magniﬁcations of boxed area (D, dysplastic lesion; and N,
adjacent normal mucosa) in serial sections are shown in (B–E, G) and (H–J), respectively. Immunostaining results for macrophage marker
F4/80 (B, H), b-catenin (C, I), Ki-67 (D, J), and BrdU (G) are shown. The arrowheads in (B, H) indicate mucosal macrophages. The inset in
(C) indicates the nuclear localization of b-catenin in epithelial cells, whereas the inset in (I) indicates weak cytoplasmic accumulation of
b-catenin. The arrows in (D, G) indicate proliferating cells that are positive for Ki-67 and BrdU, respectively. (E) Double immunoﬂuorescence
staining for F4/80 (red) and b-catenin (green) in dysplastic lesion. Arrowheads indicate macrophages. (F) The mean ratio of b-catenin-
accumulated epithelial cells and the mean number of inﬁltrated macrophages per ﬁeld in the dysplastic lesion and adjacent normal mucosa.
The arrows in (I, J) indicate normal progenitor cells localized in gland neck with mild accumulation of b-catenin and positive Ki-67 staining.
Bars indicate 100mm.
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other inﬂammatory cytokines, IL-1b, IL-6 and IL-11, which
have an important function in gastric tumorigenesis (Howlett
et al, 2005; Fox and Wang, 2007). However, these cytokines
did not promote Wnt/b-catenin activity in gastric
cancer cells, although IL-1b slightly increased the high-GFP
population in AGS–GFP cells (Supplementary Figure 7).
These results, taken together, suggest that TNF-a is one of
the important macrophage-derived factors that promote
the Wnt/b-catenin activity in gastric epithelial cells and
cancer cells.
Suppression of b-catenin phosphorylation by TNF-a
through the inhibition of GSK3b in gastric cancer cells
By a ﬂow cytometry analysis, we found that the level of
unphosphorylated b-catenin increased signiﬁcantly in Kato-
III cells when cells were treated with CM-LPS (þ) or TNF-a
(Figure 5A). By western blotting, we conﬁrmed the increased
level of unphosphorylated b-catenin in Kato-III cells stimu-
lated with CM-LPS (þ) or TNF-a (Figure 5B). These results
suggested that CM-LPS (þ) or TNF-a suppressed the phos-
phorylation of b-catenin, resulting in Wnt/b-catenin promo-
tion. Signiﬁcantly, treatment with TNF-a resulted in an
increase of GSK3b phosphorylation on Ser9 both in
AGS and Kato-III cells (Figure 5C), which caused the
suppression of the GSK3b activity (Cross et al, 1995).
The mean relative band intensities of the phosphorylated
GSK3b to the control level were 2.03±0.14 (P¼0.009)
and 1.68±0.31 (P¼0.03) in the AGS and Kato-III cells,
respectively. Interestingly, a strong immunostaining signal
for phosphorylated GSK3 was found in a sub-population
of Kato-III cells that also showed nuclear accumulation
of b-catenin at the same time (Figure 5D). These results
suggest that the promotion of Wnt/b-catenin signalling is
regulated by the GSK3b phosphorylation status in gastric
cancer cells. Akt is an important kinase for phosphorylation
of GSK3b at Ser9 (Sharma et al, 2002). Importantly, the
active form of Akt, phosphorylated on Ser473, increased
signiﬁcantly after TNF-a stimulation in both AGS and
Kato-III cells (Figure 5C). The mean relative band intensities
of the phosphorylated Akt to the control level were
2.08±0.16 (P¼0.005) and 1.81±0.19 (P¼0.002) in the
AGS and Kato-III cells, respectively. These results suggest
that TNF-a accelerates the GSK3b phosphorylation through
the activation of the Akt pathway.
NF-jB-independent promotion of Wnt/b-catenin activity
in gastric cancer cells
To examine whether NF-kB is involved in Wnt/b-catenin
promotion by activated macrophages, we transfected IkB-
superrepressor (IkBSR) expression vector into AGS–GFP
cells and established two sublines, in which TNF-a-induced
NF-kB activation was suppressed (Figure 6A). Notably, the
TNF-a- or CM-LPS (þ)-induced promotion of the Wnt/b-
catenin activity did not change in either of IkBSR-transfected
AGS–GFP cells (Figure 6B), thus suggesting the existence of
an NF-kB-independent mechanism for the TNF-a-induced
Wnt/b-catenin promotion.
When Kato-III cells were treated with the protein synthesis
inhibitor cycloheximide, the unphosphorylated b-catenin-
positive population decreased gradually in an incubation
time-dependent manner, probably due to the phosphorylation
of b-catenin by GSK3b (Figure 6C, black lines). However, the
simultaneous treatment with CM-LPS (þ) signiﬁcantly
suppressed the cycloheximide-induced decrease of this
population (Figure 6C, red lines). Therefore, it is also
possible that activated macrophages suppress b-catenin
phosphorylation independent of protein synthesis, which is
consistent with the results that the transcription factor NF-kB
pathway is not involved in the suppression of b-catenin
phosphorylation.
Macrophage inﬁltration and Wnt/b-catenin activation in
mouse gastric epithelial cells by Helicobacter infection
We next examined whether Wnt/b-catenin signalling is acti-
vated by infection-associated inﬂammation in the mouse
stomach. H. felis, a close relative of H. pylori was infected
into K19-Wnt1 mouse stomach. At 8 weeks after H. felis
infection, the inﬁltration of macrophages was found in the
H. felis-infected gastric mucosa (Figure 7A–C), whereas tis-
sue macrophages were sparsely scattered in the non-infected
mucosal area (Figure 7G–I). Such an inﬂamed mucosa in the
infected K19-Wnt1 mice was only detected by histological
examinations, and this inﬂamed mucosa was distinct from
the spontaneously developed dysplastic lesions (Figure 1A).
Figure 2 Suppression of intestinal tumorigenesis by depletion of
macrophages. (A, C) Representative photographs of small intestine
of Apc
D716 mice (A) and Apc
D716 op/op compound mutant mice (C)
were taken using a dissecting microscope. The arrowheads indicate
intestinal polyps. Bars indicate 2mm. (B, D) F4/80 macrophage
immunostaining of polyp tissues in Apc
D716 (B) and Apc
D716 op/op
compound mice (D). The arrows indicate macrophages. Bars in-
dicate 100mm. (E) The number of total polyps and large polyps
41mm in diameter of Apc
D716 (Cont) and Apc
D716 op/op compound
mice (op/op) are shown as mean±s.d. (F) BrdU labelling index in
polyps of Apc
D716 (Cont) and Apc
D716 op/op mice (op/op) are shown
as mean±s.d. *Po0.05 in comparison to the control.
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cells increased signiﬁcantly in the infected and inﬂamed
mucosa compared with that in the non-inﬂamed mucosa
(Figure 7D, J and M). These results suggest that the infec-
tion-associated inﬂammation promotes the Wnt/b-catenin
signalling activity in gastric epithelial cells in vivo.
Moreover, in the inﬂamed mucosa, the epithelial cell prolif-
eration detected by Ki-67 immunostaining signiﬁcantly in-
creased (Figure 7E, K and N). Furthermore, the number of
H
þ/K
þ-ATPase-positive parietal cells decreased dramatically
in the H. felis-infected area, thus indicating the suppression of
epithelial differentiation (Figure 7F, L and O). These results,
taken together, suggest that inﬁltrated macrophages in re-
sponse to Helicobacter infection have an important function
in the activation of Wnt/b-catenin signalling, thereby enhan-
cing the proliferation and suppression of differentiation.
When Apc
D716 mice were infected with H. felis, we did
not ﬁnd any b-catenin-accumulated dysplastic cells in the
Figure 3 Fluctuation of the Wnt/b-catenin activity in gastric cancer cells. (A) Representative results of immunocytochemistry of AGS
(top panels) and Kato-III (bottom panels) using anti-total b-catenin antibody (green) and DAPI (blue) (left panels) or anti-unphosphorylated
b-catenin antibody (red) (right panels) of the same specimen. The arrows indicate cells with accumulated both total and unphosphorylated
b-catenin. The arrowheads indicate cells with weak or loss of b-catenin staining. (B) Construction of TOPEGFP expression vector. EGFP cDNA
was inserted between TCF-binding site/TK minimum promoter and SV40 pA signal. (C) Representative results of immunocytochemistry of
Kato-III–GFP cells transiently transfected with pcDNA3-S33A-b-catenin for 72h. GFP expression (green) with DAPI staining (blue) (left panel),
and unphosphorylated b-catenin (red) of the same specimen (right panel) are shown. The arrows indicate the cell cluster with elevated GFP
and unphosphorylated b-catenin levels. (D) Representative results of ﬂow cytometry for GFP ﬂuorescence of AGS–GFP (top) and Kato-III–GFP
(bottom) cells. Flow cytometry results of the isolated high-GFP (top 5%, red line) and low-GFP (bottom 5%, blue line) populations at 0h
(centre) and 5 days (right) after isolation by cell sorting.
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&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 12 | 2008 1675Figure 4 Enhancement of Wnt/b-catenin signalling by the activated macrophages in gastric cancer cells. (A, B) Representative results of ﬂow
cytometry of AGS–GFP (A) and Kato-III–GFP cells (B). The cells were treated with CM-LPS (þ) (top), CM-LPS ( ) (middle) or LPS alone
(bottom) at various concentrations indicated on top of each panel. The red area in each panel indicates a population with a high GFP intensity
corresponding to the top 2% of the control cells (left). The percentage of high-GFP population (red area) is indicated in each panel.
(C) Representative ﬂow cytometry of AGS–GFP (top) and Kato-III–GFP (bottom) treated with CM-LPS (þ) alone (centre) or CM-LPS (þ) with
anti-TNF-a-neutralizing antibody (right). The percentage of a high-GFP population (red area corresponding to top 2% in control cells, left) is
indicated in each panel. (D) Representative ﬂow cytometry results of AGS–GFP (top) and Kato-III–GFP (bottom) treated with TNF-a (red lines)
and untreated control (black lines). The percentage of high GFP in TNF-a-treated cells (corresponding to top 2% in control cells, grey area) is
indicated in each panel.
Wnt promotion by activated macrophages
K Oguma et al
The EMBO Journal VOL 27 | NO 12 | 2008 &2008 European Molecular Biology Organization 1676Figure 5 Suppression of b-catenin phosphorylation by CM-LPS (þ) or TNF-a in gastric cancer cells. (A) Representative ﬂow cytometry results
of Kato-III cells using an antibody against unphosphorylated b-catenin on Ser37 and Thr41 are shown. The cells were treated with CM-LPS (þ)
(centre) or TNF-a (right) for 24h. The red area indicates population with high level of unphosphorylated b-catenin: top 10% in control cells
(left). The percentage of red area is indicated in each panel. (B) Western blotting of Kato-III cells for total b-catenin (top) and unphosphorylated
b-catenin (middle). The cells were treated with CM-LPS (þ) (CM) or TNF-a at 10ng/ml (TNF). b-Actin was used as an internal control
(bottom). (C) Western blotting of AGS cells (left) and Kato-III cells (right) for total and phosphorylated GSK3b on Ser9, and phosphorylated Akt
on Ser473. b-Actin was used as an internal control. The cells were treated with TNF-a at 100ng/ml (TNF) in serum-free conditions. The results
of three independent samples are shown for each cell line. (D) Representative immunocytochemistry for phosphorylated GSK3 (p-GSK, green)
and DAPI (blue) (left) and unphosphorylated b-catenin (red) (right) of the same specimen. The arrows indicate cells with strong staining for
both p-GSK and b-catenin, whereas the arrowheads indicate cells with weak staining for both.
Figure 6 NF-kB-independent promotion of the Wnt/b-catenin signalling activity. (A) The level of NF-kB activity in the TNF-a-treated (TNF) or
untreated control (Con.) cells (mean±s.d.). IkBSR nos. 1 and 2 are AGS–GFP-derived stable transfectants with IkBSR, whereas IkBSR
( ) indicates parental AGS–GFP. (B) Representative ﬂow cytometry results of IkBSR( ), IkBSR nos. 1 and 2 cells (left to right) treated with
TNF-a (top) or CM-LPS (þ) (bottom) at the indicated concentrations (red lines). The percentage of high-GFP populations (corresponding to
top 2% in untreated cells, black lines) is indicated in each panel. (C) Flow cytometry results of Kato-III cells using antibody against
unphosphorylated b-catenin. The cells were treated with cycloheximide alone (black line) or cycloheximide and CM-LPS (þ) (red line) for 2, 4,
8 and 12h. The percentages of the population with high level of unphosphorylated b-catenin are indicated in each panel (red, cycloheximide
and CM-LPS (þ); black, cycloheximide alone).
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possible that the basal activation level of Wnt/b-catenin
signalling is required for its promotion.
Tumour development in H. felis-infected K19-Wnt1
mouse stomach
We ﬁnally examined whether H. felis infection contributes
to gastric tumorigenesis in K19-Wnt1 mice. Importantly,
K19-Wnt1 mice developed gastric tumours at 20 weeks
after H. felis infection, whereas no tumours were found
in the H. felis-infected wild-type mice (Figure 8A and E).
Histologically, submucosal inﬁltration was found in both
H. felis-infected K19-Wnt1 and wild-type mouse stomach
(Figure 8B and F). Although macrophage inﬁltration
was detected in both genotypes (Figure 8C and G),
dysplastic epithelial cells were evident in the infected
K19-Wnt1 tumours but not in the wild-type mouse stomach
(Figure 8D and H). These results, taken together, suggest
that infection-associated inﬂammation has an important
function in gastric tumorigenesis through the promotion
of the Wnt/b-catenin activity beyond the basal activation
level.
Discussion
Macrophage inﬁltration and cancer development,
progression and stemness
The activation of Wnt/b-catenin signalling by genetic altera-
tion, such as mutation in APC or CTNNB1, is responsible for
gastrointestinal tumorigenesis. However, accumulating evi-
dence suggests that further promotion of the Wnt/b-catenin
activity has an important function in tumour growth and
progression (Fodde and Brabletz, 2007). For example, in-
creased b-catenin accumulation is found in the invasion
front of colon cancer (Brabletz et al, 1998). We herein
demonstrated direct evidence that the Wnt/b-catenin activity
ﬂuctuates in individual cancer cells that carry the same
genetic alteration in CTNNB1. Accordingly, Wnt/b-catenin
signalling can be promoted beyond the basal activated level
caused by genetic alteration, and such promotion may have
an important function in both tumour development and
progression.
We have previously shown the induction of COX-2/PGE2
pathway to have an important function in the intestinal
tumorigenesis that is triggered by Wnt/b-catenin activation
(Oshima et al, 1996; Sonoshita et al, 2001). The simultaneous
Figure 7 The activation of Wnt/b-catenin signalling in H. felis-infected gastric mucosa of K19-Wnt1 mice. (A–F) Representative histology of
inﬂamed gastric mucosa (IM) of K19-Wnt1 mice infected with H. felis for 8 weeks. (G–L) Non-inﬂamed gastric mucosal (NIM) area of the K19-
Wnt1 mice. H&E staining (A, G), high magniﬁed H&E staining (B, H), immunostaining for F4/80 (C, I), unphosphorylated b-catenin (D, J), Ki-
67 (E, K) and H
þ/K
þ-ATPase (F, L). Bars in (B, H) and other panels indicate 50 and 100mm, respectively. The arrows in (A, C) indicate
inﬁltrated mononuclear cells and macrophages, respectively. The yellow arrowheads in (B) indicate Helicobacter bacteria in the gland lumen,
which is not found in NIM (H). The arrows in (D, E) indicate b-catenin-accumulated and proliferating epithelial cells, respectively. The arrows
in (F) indicate H
þ/K
þ-ATPase-positive parietal cells that are dramatically decreased in IM compared with NIM (L). The arrows in (J, K)
indicate progenitor cells with cytoplasmic b-catenin accumulation and Ki-67-positive proliferation, respectively. The mean numbers of positive
cells per gland for unphosphorylated b-catenin (M), Ki-67 (N), and H
þ/K
þ-ATPase (O) in IM (red bars) and NIM (blue bars) are shown as
histograms (mean±s.d.). The asterisks indicate Po0.05.
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for gastric tumour development in mouse models (Oshima
et al, 2006). Although PGE2 may have multiple functions for
tumorigenesis, we previously found an increased PGE2 level to
result in macrophage accumulation in the gastric mucosa of
K19-C2mE mice (Oshima et al,2 0 0 4 ) .A c c o r d i n g l y ,i ti sp o s s i b l e
that macrophage inﬁltration in dysplastic lesions of K19-Wnt1
mice is caused by the spontaneous induction of COX-2/PGE2
pathway. We herein show that Wnt/b-catenin signalling is
promoted by macrophage-derived TNF-a, which contributes to
gastric tumorigenesis. It is therefore possible that the induction
of the COX-2/PGE2 pathway promotes Wnt/b-catenin signalling
through the enhancement of macrophage inﬁltration, which is
responsible for tumour development.
On the other hand, Wnt/b-catenin signalling is not acti-
vated in the stomach of either K19-C2mE mice or H. felis-
infected Apc
D716 mice, thus indicating that the induction of
the COX-2/PGE2 pathway and subsequent macrophage inﬁl-
tration are not sufﬁcient for the promotion of Wnt/b-catenin
in gastric epithelial cells. It is conceivable that the basal
activation of the Wnt/b-catenin pathway by genetic alteration
is required for the promotion of Wnt/b-catenin signalling.
The activation of Wnt/b-catenin pathway is also suggested
to be important for stemness. Wnt/b-catenin signalling is
required for the maintenance of normal intestinal stem cells
(Korinek et al, 1998), and the increase in the Wnt/b-catenin
activity contributes to the maintenance of stemness in ES cells
(Kielman et al, 2002). Accordingly, it is possible that the
increased Wnt/b-catenin activity is also important for the
maintenance of cancer stem cells. Therefore, inﬁltrated macro-
phages in tumour tissues may be an important component of
niche for cancer stem cells by promoting Wnt/b-catenin signal-
ling through TNF-a p a t h w a y .T h i sh y p o t h e s i si ss u p p o r t e db y
the results that macrophages are required for the maintenance
of progenitor cells in the intestinal crypt (Pull et al,2 0 0 5 ) .
Possible pathways other than TNF-a for the promotion
of the Wnt/b-catenin signalling activity
It has been shown that inﬂammatory cytokines, TNF-a,
IL-1b, IL-6 or IL-11, have an important function in gastric
tumorigenesis (Howlett et al, 2005; Fox and Wang, 2007).
Among these cytokines, TNF-a is the most potent
Wnt/b-catenin-promoting factor, although IL-1b slightly
increases Wnt signalling in AGS cells. However, the increased
level of the Wnt/b-catenin activity by CM-LPS (þ) is sig-
niﬁcantly higher than that by TNF-a alone in both cell lines
(Figure 4), thus suggesting the effect of other macrophage-
derived factors on Wnt/b-catenin promotion. It has
been reported that hepatocyte growth factor activates Wnt/
b-catenin signalling through the tyrosine phosphorylation
of b-catenin (Rasola et al, 2006), and platelet-derived
growth factor also promotes Wnt/b-catenin signalling
through suppression of b-catenin phosphorylation (Yang
et al, 2006). It is therefore possible that these factor(s)
contribute to Wnt/b-catenin promotion together with
TNF-a in gastric tumorigenesis.
Recently, using a colon tumour mouse model, TNF R1
signalling in bone marrow-derived cells has been shown to
indirectly enhance epithelial Wnt/b-catenin signalling
(Popivanova et al, 2008). Accordingly, it is possible that
TNF-a signalling, not only in epithelial cells but also in
stromal cells, may therefore contribute to the promotion of
Wnt/b-catenin signalling in cancer cells.
Promotion of Wnt/b-catenin signalling in cancer cells
that retain wild-type CTNNB1
We show here that TNF-a stimulation promotes the
Wnt/b-catenin signalling activity through the suppression
of b-catenin phosphorylation by GSK3b. Therefore, the
expression of wild-type b-catenin is required for the
promotion of Wnt/b-catenin signalling in epithelial cells as
well as cancer cells. Because Kato-III cells have a multicopy of
the wild-type CTNNB1 (Suriano et al, 2005), TNF-a stimula-
tion suppresses phosphorylation of these b-catenin, thus
leading to the enhancement of Wnt/b-catenin signalling. On
the other hand, AGS cells possess mutation in CTNNB1 close
to the phosphorylation site of GSK3b (Supplementary Figure
2; Caca et al, 1999), which causes the activation of the
basal Wnt/b-catenin signalling. It is therefore possible that
TNF-a stimulation suppresses phosphorylation of wild-type
b-catenin expressed from retained intact CTNNB1, which
contributes to the promotion of the total Wnt/b-catenin
activity of AGS cells. In human gastric cancer, a CTNNB1
mutation is found in about 30% of the Wnt-activated
cases (Clements et al, 2002). However, either a somatic
mutation or downregulation of E-cadherin (Cheng et al,
2005), secreted frizzled-related proteins (Nojima et al,
2007), or b-TrCP, a component of ubiquitin ligase complex
(Kim et al, 2007) is found in gastric cancer, which leads to the
basal activation of Wnt/b-catenin signalling without muta-
tion in CTNNB1. These results, taken together, suggest that
wild-type b-catenin expressed in gastric cancer cells is stabi-
lized by inﬂammatory macrophages, thus resulting in the
promotion of Wnt/b-catenin signalling, which contributes to
cancer development, progression and the maintenance of
cancer stem cells.
Accordingly, the present results suggest that the suppres-
sion of macrophage inﬁltration and its activation by anti-
inﬂammatory drugs or inhibitors for PGE2 pathway is, there-
fore, a possible strategy for chemoprevention against gastric
cancer.
Figure 8 Tumour development in H. felis-infected K19-Wnt1 mouse
stomach. K19-Wnt1 (A–D) and wild-type (E–H) mouse stomach in-
fected with H. felis for 20 weeks. (A, E) Macroscopic photographs. The
arrows in (A) indicate gastric tumours that developed in the infected
K19-Wnt1 mice. H&E staining at low magniﬁcation (B, F) and high
magniﬁcation (D, H). Immunostaining results for macrophage marker
F4/80 (C, G). The arrows in (B, F) indicate submucosal inﬁltration. The
arrowheads in (D) indicate dysplastic epithelial cells. Bars in (B, F) and
( C ,D ,G ,H )i n d i c a t e2 0 0a n d4 0mm, respectively.
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Animal experiments
The construction of K19-Wnt1 and K19-C2mE transgenic mice has
been described previously (Oshima et al, 2004, 2006). Brieﬂy, K19-
Wnt1 mice express Wnt1, whereas K19-C2mE mice express COX-2
and mPGES-1 in gastric epithelial cells under transcriptional
regulation by cytokeratin 19 (K19) gene promoter. K19-Wnt1
transgenic mice were euthanized at 30 weeks of age (n¼10), and
the glandular stomach was ﬁxed with 4% paraformaldehyde and
processed for histological analysis. H. felis (ATCC49179) was
cultured as previously described (Oshima et al, 2004). H. felis
bacteria were inoculated at 10
8 per mouse p.o. into K19-Wnt mice,
Apc
D716 mice (Oshima et al, 1995) and wild-type mice. The infected
K19-Wnt1 mice were examined at 8 and 20 weeks after the H. felis
inoculation (n¼3 for each mice). The infected Apc
D716 mice were
examined at 6 weeks after infection (n¼4). The localization of H.
felis-infected mucosa at 8 weeks was estimated by the detection of
bacteria using microscope with  100 objective (Figure 7B). Apc
D716
mice were crossed with op/op mice (The Jackson Laboratory) to
obtain Apc
D716 op/op compound mice (n¼3) and littermate control
Apc
D716 mice (n¼3). The intestine of Apc
D716 and Apc
D716 op/op
mice was examined at 12 weeks of age, and the total number of
polyps was determined using a dissecting microscope. For scoring
the BrdU labelling index, the mice were injected i.p. with 200mlo f
BrdU solution (Roche) and then the tissue specimens were
processed for immunostaining using anti-BrdU antibody. All animal
experiments were carried out according to the protocol approved by
the Committee on Animal Experimentation of Kanazawa University.
Histology and immunostaining
The stomach tissues were ﬁxed in 4% paraformaldehyde, parafﬁn-
embedded and sectioned at 4mm thickness. These sections were
stained with H&E. Serial sections were immunostained with
antibodies for Ki-67 (DakoCytomation), F4/80 (Serotec), unpho-
sphorylated (activated) b-catenin on Ser37 and Thr41 (Upstate),
H
þ/K
þ-ATPase (MBL, Nagoya, Japan) or BrdU (BD Biosciences) as
the primary antibody. The staining signals were visualized using the
Vectorstain Elite Kit (Vector Laboratories). The number of positive
stained cells for F4/80, b-catenin, Ki-67 or H
þ/K
þ-ATPase was
scored in 20 randomly selected gastric glands and the mean values
were calculated. The number of BrdU-positive cells and the total
number of nuclei was counted in ﬁve microscopic ﬁelds and then
the mean value was calculated as the BrdU labelling index. For
immunoﬂuorescence staining, Alexa Fluor 594 donkey anti-mouse
IgG or Alexa Fluor 488 anti-rat or rabbit IgG (Molecular Probes) was
used as the secondary antibody.
Plasmid vector construction
For the construction of the b-catenin/TCF reporter plasmid with
GFP (TOPEGFP vector), cDNA encoding EGFP was excised from
pIRES2-EGFP (Clontech) and replaced with luciferase gene in
TOPFLASH plasmid (Upstate). TOPEGFP reporter plasmid was
transfected to cells using Effectene Transfection Reagent (Qiagen),
and stable cell lines were then obtained by cell sorting. The Wnt/b-
catenin activity using TOPEGFP reporter was measured by ﬂow
cytometry (see below). pcDNA3-S33A-b-catenin and pBSFI-IkBSR
plasmids were kindly provided by Dr Peter Vogt at the Scripps
Research Institute. pcDNA3-S33A-b-catenin was transiently trans-
fected to Kato-III–GFP cells for 72h to express stabilized mutant b-
catenin. pBSFI-IkBSR was transfected to AGS–GFP cells to establish
the sublines in which the NF-kB pathway is suppressed.
Immunocytochemistry
Gastric cancer cells grown on cover slips were ﬁxed with 10%
neutral buffered formalin and permeabilized with 0.1% Triton X-
100 in PBS. Anti-total b-catenin antibody (Sigma), anti-unpho-
sphorylated b-catenin antibody (Upstate), or anti-phosphorylated
GSK3 (Cell Signaling) was used as the primary antibody, and anti-
mouse IgG Alexa 594 or anti-rat IgG Alexa 488 (Molecular Probes)
were used as the secondary antibody. Next, cover slips were
mounted using VECTASHIELD Mounting Medium (Vector Labora-
tories) that contained DAPI for nuclear staining.
Cell culture and preparation of conditioned medium
Gastric cancer cell lines, AGS (ATCC) and Kato-III (Cell Resource
Center for Biomedical Research, Tohoku University, Japan) were
cultured in RPMI1640 medium supplemented with 10% FBS in a
humidiﬁed incubator at 371C with 5% CO2. The mouse macrophage
cell line RAW264 (RIKEN BioResource Center, Tsukuba, Japan) was
cultured in RPMI1640, and treated with LPS puriﬁed from
Salmonella enterica serotype typhimurium (Sigma) at 100ng/ml
for 24h. The conditioned medium, CM-LPS (þ) was collected and
used for the Wnt/b-catenin activation experiments. The control
conditioned medium, CM-LPS ( ) was prepared from non-
stimulated RAW264 cell culture. For either the stimulation or
inhibition of the TNF-a pathway, TNF-a (Calbiochem) or anti-
mouse TNF-a-neutralizing antibody (R&D systems) was added,
respectively, in the culture medium at the indicated concentration.
NF-jB ELISA assay
The nuclear extract was prepared from AGS–GFP cells or pBSFI-IkBSR-
transfected clones (IkBSR nos. 1 and 2) using NE-PER Nuclear
Extraction Reagents (Pierce), and the NF-kB activity was measured
using an NF-kB p65 Transcription Factor Assay Kit (Active Motif). These
cell lines were also used for the ﬂow cytometry analysis.
Flow cytometry analysis
After treatment with CM-LPS (þ), CM-LPS ( ), LPS or TNF-a at the
indicated concentrations for 48h, AGS–GFP, Kato-III–GFP cells or
pBSFI-IkBSR-transfected cells (IkBSR nos. 1 and 2) were washed
with PBS containing 2% FCS and stained with 5mg/ml propidium
iodide to exclude dead cells. GFP ﬂuorescence was examined with
FACSCalibur (Becton Dickinson). A ﬂuorescence intensity correspond-
ing to the top 2% of the control untreated cells was judged as the high-
G F Pp o p u l a t i o n( h i g h - W n t / b-catenin signalling population).
For the analysis of intracellular unphosphorylated (active) b-
catenin, cells were ﬁxed in 1–2% paraformaldehyde and permea-
bilized using 0.05% Triton X-100 in PBS containing 2% FCS. Next,
the cells were incubated with anti-unphosphorylated b-catenin
antibody on Ser37 and Thr41 (Upstate) followed by anti-mouse IgG-
Alexa 488 (Molecular Probes), and examined with FACSCalibur. For
the inhibition of protein translation, the cells were treated with
cycloheximide (Sigma) at 0.5mg/ml for the indicated time, and then
the intracellular unphosphorylated b-catenin was measured by a
FACS analysis as described above.
Western blotting analysis
For the detection of total b-catenin and unphosphorylated b-
catenin, the cells were stimulated with CM-LPS (þ) or TNF-a at
10ng/ml for 24h. For the detection of total or phosphorylated
GSK3b (Ser9), and phosphorylated Akt (Ser473), the cells were
cultured in serum-free conditions for 24h followed by stimulation
with TNF-a at 100ng/ml for 24h. Next, the cells were lysed and
sonicated in lysis buffer. After centrifugation at 20000g,1 0mg of the
supernatant protein was separated in a 10% SDS-polyacrylamide
gel. Antibodies for unphosphorylated (active) b-catenin (Upstate),
total b-catenin (Sigma), total GSK3b (BD Biosciences), phosphory-
lated GSK3 on Ser9 and 21 (Cell Signaling), and phosphorylated Akt
at Ser473 (Cell Signaling) were used as the primary antibody. b-
Actin was used as an internal control. The ECL detection system
(Amersham Biosciences) was used to detect speciﬁc signals.
Statistical analysis
The data were analysed by the paired or unpaired t-test using
Microsoft Excel (Microsoft). A value of Po0.05 was accepted as
statistically signiﬁcant.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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